Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -27.03%731.39M | 0.83%1.94B | 19.94%1B | 29.24%1.93B | 9.28%835.64M | -26.69%1.49B | -22.96%764.72M | 26.73%2.04B | 58.77%992.64M | 7.39%1.61B |
| Operating income | -27.03%731.39M | 0.83%1.94B | 19.94%1B | 29.24%1.93B | 9.28%835.64M | -26.69%1.49B | -22.96%764.72M | 26.73%2.04B | 58.77%992.64M | 7.39%1.61B |
| Cost of sales | 23.70%-672.93M | 1.00%-1.73B | -12.71%-881.94M | -20.02%-1.75B | -7.14%-782.47M | 19.14%-1.46B | 15.87%-730.31M | -25.99%-1.8B | -50.33%-868.06M | -2.40%-1.43B |
| Operating expenses | 23.70%-672.93M | 1.00%-1.73B | -12.71%-881.94M | -20.02%-1.75B | -7.14%-782.47M | 19.14%-1.46B | 15.87%-730.31M | -25.99%-1.8B | -50.33%-868.06M | -2.40%-1.43B |
| Gross profit | -51.43%58.46M | 18.54%213.73M | 126.35%120.37M | 405.55%180.29M | 54.58%53.18M | -84.77%35.66M | -72.39%34.4M | 32.71%234.2M | 160.62%124.58M | 77.31%176.47M |
| Selling expenses | 4.37%-31.97M | -23.55%-69.83M | -30.72%-33.43M | -12.94%-56.53M | 1.36%-25.57M | 9.38%-50.05M | 13.18%-25.92M | -5.07%-55.23M | -35.82%-29.86M | -24.31%-52.57M |
| Administrative expenses | -13.22%-10.56M | -7.98%-29.85M | 14.23%-9.33M | -26.81%-27.65M | -16.81%-10.88M | -7.27%-21.8M | 2.51%-9.31M | -5.35%-20.32M | -2.68%-9.55M | -12.25%-19.29M |
| Impairment and provision | -4,469.23%-594K | 416.22%702K | 96.65%-13K | -1,485.71%-222K | 31.33%-388K | 98.22%-14K | -730.88%-565K | -197.35%-785K | -44.68%-68K | -17.86%-264K |
| -Other impairment is provision | -4,469.23%-594K | 416.22%702K | 96.65%-13K | -1,485.71%-222K | 31.33%-388K | 98.22%-14K | -730.88%-565K | -197.35%-785K | -44.68%-68K | -17.86%-264K |
| Special items of operating profit | -36.62%2.3M | -4.12%11.78M | -18.37%3.62M | -4.91%12.28M | -11.55%4.44M | 4,866.05%12.92M | 3,560.58%5.02M | -135.24%-271K | -96.31%137K | -84.83%769K |
| Operating profit | -78.29%17.63M | 16.95%126.52M | 290.91%81.22M | 564.60%108.18M | 474.74%20.78M | -114.78%-23.29M | -95.76%3.62M | 49.92%157.59M | 322.31%85.24M | 134.13%105.12M |
| Financing cost | 28.56%-7.28M | 9.43%-18.25M | -5.41%-10.19M | 2.98%-20.15M | 16.06%-9.66M | 9.49%-20.77M | -0.26%-11.51M | -13.13%-22.94M | -38.03%-11.48M | 5.35%-20.28M |
| Earning before tax | -85.42%10.35M | 22.98%108.27M | 539.09%71.04M | 299.85%88.04M | 240.79%11.12M | -132.72%-44.05M | -110.70%-7.9M | 58.71%134.65M | 521.56%73.76M | 261.49%84.84M |
| Tax | 102.37%213K | -47.01%-15.57M | -824.92%-8.98M | -182.75%-10.59M | -135.30%-971K | 135.02%12.8M | 129.37%2.75M | -194.14%-36.55M | -618.25%-9.37M | -1,111.07%-12.43M |
| After-tax profit from continuing operations | -82.97%10.57M | 19.70%92.7M | 511.73%62.05M | 347.80%77.45M | 297.20%10.14M | -131.86%-31.25M | -107.99%-5.14M | 35.47%98.1M | 509.62%64.39M | 193.19%72.41M |
| After-tax profit from non-continuing business | -211.49%-194K | ---- | --174K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | -83.33%10.37M | 19.70%92.7M | 513.45%62.23M | 347.80%77.45M | 297.20%10.14M | -131.86%-31.25M | -107.99%-5.14M | 35.47%98.1M | 509.62%64.39M | 193.19%72.41M |
| Profit attributable to shareholders | -83.33%10.37M | 19.70%92.7M | 513.45%62.23M | 347.80%77.45M | 297.20%10.14M | -131.86%-31.25M | -107.99%-5.14M | 35.47%98.1M | 509.62%64.39M | 193.19%72.41M |
| Basic earnings per share | -83.33%0.0171 | 15.38%0.15 | 413.00%0.1026 | 360.00%0.13 | 300.00%0.02 | -131.25%-0.05 | -109.09%-0.01 | 33.33%0.16 | 450.00%0.11 | 200.00%0.12 |
| Diluted earnings per share | -83.33%0.0171 | 15.38%0.15 | 413.00%0.1026 | 360.00%0.13 | 300.00%0.02 | -131.25%-0.05 | -109.09%-0.01 | 33.33%0.16 | 450.00%0.11 | 200.00%0.12 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | PwC accounting firm | -- | KPMG | -- | PwC accounting firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.